1887

Abstract

We evaluated 3122 children with urinary isolates over a 10 year period in order to assess the emergence of fluoroquinolone resistance. Susceptibilities remained stable; however, hospitalized children had a statistically higher risk of developing fluoroquinolone-resistant isolates when compared with outpatients. Stewardship monitoring of fluoroquinolone use amongst hospitalized children is warranted.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000072
2015-07-01
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/7/778.html?itemId=/content/journal/jmm/10.1099/jmm.0.000072&mimeType=html&fmt=ahah

References

  1. Boyd L.B., Atmar R.L., Randall G.L., Hamill R.J., Steffen D., Zechiedrich L.. ( 2008;). Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis 8: 4 [CrossRef] 18197977.
    [Google Scholar]
  2. Bradley J.S., Jackson M.A., Committee on Infectious Diseases & American Academy of Pediatrics. ( 2011;). The use of systemic and topical fluoroquinolones. Pediatrics 128: e1034–e1045 [CrossRef] 21949152.
    [Google Scholar]
  3. CLSI ( 2006;). Analysis and presentation of cumulative antimicrobial susceptibility test data Approved Guideline, 2nd edn, M39-A2. Wayne PA: Clinical and Laboratory Standards Institute;.
    [Google Scholar]
  4. Edlin R.S., Shapiro D.J., Hersh A.L., Copp H.L.. ( 2013;). Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 190: 222–227 [CrossRef] 23369720.
    [Google Scholar]
  5. Fleming V.H., White B.P., Southwood R.. ( 2014;). Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital. Am J Emerg Med 32: 864–870 [CrossRef] 24877721.
    [Google Scholar]
  6. Kim J.Y., Lautenbach E., Chu J., Goyal M., Nachamkin I., McGowan K., Coffin S., Zaoutis T.. ( 2008;). Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli Klebsiella species. Am J Infect Control 36: 70–73 [CrossRef] 18241740.
    [Google Scholar]
  7. Linder J.A., Huang E.S., Steinman M.A., Gonzales R., Stafford R.S.. ( 2005;). Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118: 259–268 [CrossRef] 15745724.
    [Google Scholar]
  8. Rose L., Coulter M.M., Chan S., Hossain J., Di Pentima M.C.. ( 2014;). The quest for the best metric of antibiotic use and its correlation with the emergence of fluoroquinolone resistance in children. Pediatr Infect Dis J 33: e158–e161 [CrossRef] 24830523.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000072
Loading
/content/journal/jmm/10.1099/jmm.0.000072
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error